Newport

Newport Premium, Global, and Sourcing solutions are used across the globe by generics, API manufacturers, and innovators alike to target products for development and licensing, source active ingredients, and monitor competition.

Whether you want to get the basics and get started fast — or fine tune your skills, Thomson Reuters can help with a variety of targeted training opportunities. Classes are conducted over the internet — some live with open question-and-answer sessions — and others prerecorded so you can take advantage of them at your convenience, around the clock.

We invite you to explore the following Newport training opportunities.

LATEST ENHANCEMENTS IN NEWPORT (30 minutes)

Over the next month customers will see new features and enhanced content being integrated into the Newport systems. Learn where to find the new features as well as how to get the most out of the new content by joining this 30 minute training session.

During this session, attendees will learn more about:

  • Additional details about the status of SPCs
  • US ANDA filing information
  • Improved visibility & search ability for completed US DMFs
  • NCDs in Croatia & Canada
  • Increased GMP certifications
  • Select device approval information
  • Improved manufacturing capabilities information
  • Additional global regulatory agency inspection dates

Join us for this training session and get an opportunity to ask questions to our content specialist.

Wednesday, July 16, 2014
9am San Francisco - 11am Chicago - 12pm New York - 5pm London
TARGETING GENERIC PRODUCTS & COMPANIES TO EXPAND YOUR PORTFOLIO WITH NEWPORT (45 minutes)

In this 45 minute session you'll learn how Newport can support you in identifying launch opportunities as well as new partners or acquisition candidates to help open up new markets.  We will also cover how to quickly find and evaluate sources of API in different markets.  Here are just some of the questions we will look at answering:

  • Which drugs are running out of protection in the next 5 or 10 years?
  • Which drugs have been launched as tablet but not injectable? Where?
  • Who is manufacturing a specific API? Where?

Tuesday, August 12, 2014
11am San Francisco – 1pm Chicago – 2pm New York

Newport Recorded Webinar Sessions

US Follow-on Biologic Market: Developments and Forecasts

Using Newport to Understand and Track Global Generic Industry Deal-making

Support & Training Materials

Product Page & Factsheets

Product Add-ons

Life Sciences Resources

In one place, we've gathered the information that can help you enhance your discovery and development activities, and arm your decision-making. View the Life Sciences Resources to subscribe to our complimentary issues of white papers and quarterly reports.